Shanghai INT Medical Instruments Co., Ltd. (INT Medical) disclosed that on 03 June 2026, 71.79 million domestic shares were converted into an equal number of H shares.
Prior to the transaction, the company’s Hong Kong register comprised 139.41 million H shares. Post-conversion, the H-share count has risen to 211.20 million, representing a 33.99% expansion in the listed float.
The domestic-share register has been fully extinguished—falling from 71.79 million to zero—while INT Medical’s total issued share capital remains unchanged at 211.20 million shares.
The board confirmed that the conversion and listing were authorised and executed in accordance with Hong Kong Listing Rules and all relevant regulatory requirements. Chairman and Executive Director Liang Dongke submitted the return.
Comments